Sage Therapeutics, Inc. SEC Filings https://investor.sagerx.com/ Sage Therapeutics, Inc. SEC Filings en 4: Statement of changes in beneficial ownership of securities https://investor.sagerx.com/sec-filings/sec-filing/4/0001562180-19-002767 Sage Therapeutics, Inc. Fri, 10 May 2019 16:38:40 -0400 Sage Therapeutics, Inc. SEC Filings 10236 4: Statement of changes in beneficial ownership of securities https://investor.sagerx.com/sec-filings/sec-filing/4/0001562180-19-002643 Sage Therapeutics, Inc. Mon, 06 May 2019 18:24:08 -0400 Sage Therapeutics, Inc. SEC Filings 10221 8-K: Report of unscheduled material events or corporate event https://investor.sagerx.com/sec-filings/sec-filing/8-k/0001193125-19-133822 Sage Therapeutics, Inc. Thu, 02 May 2019 07:27:55 -0400 Sage Therapeutics, Inc. SEC Filings 10206 10-Q: Quarterly report which provides a continuing view of a company's financial position https://investor.sagerx.com/sec-filings/sec-filing/10-q/0001564590-19-015034 Sage Therapeutics, Inc. Thu, 02 May 2019 07:19:55 -0400 Sage Therapeutics, Inc. SEC Filings 10196 DEFA14A: Additional proxy soliciting materials - definitive https://investor.sagerx.com/sec-filings/sec-filing/defa14a/0001193125-19-119616 Sage Therapeutics, Inc. Thu, 25 Apr 2019 16:06:57 -0400 Sage Therapeutics, Inc. SEC Filings 10176 DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") https://investor.sagerx.com/sec-filings/sec-filing/def-14a/0001193125-19-119608 Sage Therapeutics, Inc. Thu, 25 Apr 2019 16:06:55 -0400 Sage Therapeutics, Inc. SEC Filings 10171 4: Statement of changes in beneficial ownership of securities https://investor.sagerx.com/sec-filings/sec-filing/4/0001562180-19-002013 Sage Therapeutics, Inc. Fri, 22 Mar 2019 16:26:53 -0400 Sage Therapeutics, Inc. SEC Filings 10146 4: Statement of changes in beneficial ownership of securities https://investor.sagerx.com/sec-filings/sec-filing/4/0001562180-19-001988 Sage Therapeutics, Inc. Wed, 20 Mar 2019 20:51:19 -0400 Sage Therapeutics, Inc. SEC Filings 10141 8-K: Report of unscheduled material events or corporate event https://investor.sagerx.com/sec-filings/sec-filing/8-k/0001193125-19-079860 Sage Therapeutics, Inc. Wed, 20 Mar 2019 06:06:51 -0400 Sage Therapeutics, Inc. SEC Filings 10136 4: Statement of changes in beneficial ownership of securities https://investor.sagerx.com/sec-filings/sec-filing/4/0001562180-19-001850 Sage Therapeutics, Inc. Mon, 11 Mar 2019 17:06:55 -0400 Sage Therapeutics, Inc. SEC Filings 10126